Ecaterina I. Dumbrava
YOU?
Author Swipe
View article: Engineered T-cell Receptor T Cells for Cancer Immunotherapy
Engineered T-cell Receptor T Cells for Cancer Immunotherapy Open
Engineering immune cells to target cancer is a rapidly advancing technology. The first commercial products, chimeric-antigen receptor (CAR) T cells, are now approved for hematologic malignancies. However, solid tumors pose a greater challe…